Hypersensitivity ReactionsMarch 23, 20266 min read

Everything You Need to Know About Type IV (delayed-type) for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for Type IV (delayed-type). Include First Aid cross-references.

Type IV hypersensitivity is the one that feels “slow” on purpose: no antibodies, no complement, no immediate wheal-and-flare. Instead, it’s a T-cell–driven, cytokine-mediated inflammatory reaction that shows up hours to days after exposure. On Step 1, it’s a favorite because it links together Th1/Th17 biology, macrophage activation, granulomas, contact dermatitis, and TB testing—all with predictable timing and classic histology.


Where Type IV Fits in the Hypersensitivity Lineup

TypeImmune mechanismKey mediatorsTimingClassic examples
IImmediate (allergic)IgE, mast cells, histamineMinutesAnaphylaxis, asthma, urticaria
IIAntibody-mediatedIgG/IgM vs cell surface/ECMHours–daysAIHA, Goodpasture, ITP
IIIImmune complexIgG immune complexes, complementHours–daysSerum sickness, PSGN, SLE
IVDelayed, cell-mediatedT cells (Th1/Th17, CD8+), macrophages48–72 hr (often)PPD, contact dermatitis, granulomatous inflammation

High-yield slogan: Type IV = “T cells take time.”


Definition (What You Should Say on an NBME)

Type IV (delayed-type) hypersensitivity is a T-cell–mediated immune reaction causing tissue inflammation and injury, typically occurring 24–72 hours after antigen exposure. It does not require antibody.

First Aid cross-reference: Immunology → Hypersensitivity reactions (Type IV: delayed, T-cell mediated; examples: contact dermatitis, TB skin test, granulomas).


Pathophysiology: Two Major Arms You Need to Know

1) Delayed-type hypersensitivity (DTH): Th1/Th17 → macrophages/neutrophils

This is the classic PPD framework.

Step-by-step:

  1. Sensitization phase (first exposure)
    • Antigen is taken up by APCs and presented on MHC II.
    • Naive CD4+ T cells differentiate into:
      • Th1 (via IL-12) → makes IFN-γ
      • Th17 → recruits neutrophils (via IL-17)
  2. Elicitation phase (re-exposure)
    • Memory Th1/Th17 cells recognize antigen and release cytokines.
    • IFN-γ activates macrophages → inflammation, induration, possible tissue damage.
    • Peaks around 48–72 hours.

What you see clinically: firm induration (cellular infiltrate), not a “histamine wheal.”

First Aid cross-reference: Immunology → T-cell subsets/cytokines (Th1: IFN-γ activates macrophages; Th17: neutrophil recruitment).


2) Cytotoxic T-cell–mediated injury: CD8+ killing

Some Type IV reactions are primarily CD8+ T cells recognizing antigen on MHC I, leading to direct cell death.

Mechanisms:

  • Perforin/granzyme
  • Fas–FasL apoptosis

High-yield associations:

  • Many autoimmune patterns and drug reactions are described under T-cell mechanisms; on Step exams, the key is recognizing “no antibodies; T cells do the damage.”

Classic Clinical Presentations (Know These Cold)

1) Contact dermatitis

Trigger: small molecules (haptens) that bind skin proteins and become immunogenic.

Common culprits:

  • Poison ivy/oak (urushiol)
  • Nickel
  • Latex
  • Fragrances/cosmetics
  • Topical antibiotics (e.g., neomycin—commonly tested conceptually)

Presentation:

  • Pruritic, erythematous, vesicular rash at site of contact
  • Appears 1–3 days after exposure (often after prior sensitization)

Histology/vibe: spongiotic dermatitis + lymphocytes (you don’t usually need the micro details, but the timing + trigger is gold).

First Aid cross-reference: Immunology → Hypersensitivity type IV examples; Dermatology rashes (contact dermatitis).


2) Tuberculin skin test (PPD)

What it tests: prior sensitization to Mycobacterium tuberculosis antigens (or BCG vaccination / some nontuberculous mycobacteria).

Timing: read at 48–72 hours.

What you measure: induration (not erythema).

Mechanism: memory Th1 cells → IFN-γ → macrophage activation → local inflammation.

First Aid cross-reference: Microbiology → Mycobacteria; Immunology → Type IV hypersensitivity.


3) Granulomatous inflammation

Granulomas are basically the immune system “walling off” something it can’t eliminate.

Mechanism: persistent antigen → chronic Th1 response → IFN-γ activates macrophages → epithelioid histiocytes + giant cells.

High-yield causes:

  • TB (caseating granulomas)
  • Histoplasma and other fungi (can be granulomatous)
  • Sarcoidosis (noncaseating; more Step 2/medicine vibe but appears on Step 1 too)
  • Foreign body granulomas (sutures, etc.)

First Aid cross-reference: Pathology → Chronic inflammation/granulomas; Micro → TB/fungi.


4) Transplant rejection (especially acute cellular rejection)

This is often framed as T-cell mediated:

  • Acute cellular rejection: recipient T cells attack donor tissue → interstitial inflammation, vascular involvement.

(Transplant immunology can get nuanced, but on Step 1 the takeaway is: T cells drive cellular rejection.)

First Aid cross-reference: Immunology → Transplant rejection (hyperacute vs acute vs chronic).


Diagnosis: How It’s Tested on Exams

Timing is the giveaway

  • Type I: minutes
  • Type IV: days

“Induration vs erythema”

  • For PPD and similar DTH reactions: induration = the measurement.

Patch testing (contact dermatitis)

  • Allergens applied to skin under occlusion.
  • Delayed eczematous reaction suggests Type IV.

Histology clues (when they show you a slide)

  • DTH: perivascular lymphocytes + macrophages
  • Granulomas: epithelioid macrophages, giant cells, possible central necrosis (caseating in TB)

Treatment: What to Do (and What the Question Writer Wants)

General principles

  • Avoid the trigger (key for contact dermatitis)
  • Control inflammation:
    • Topical corticosteroids for localized dermatitis
    • Systemic corticosteroids for severe/widespread reactions (e.g., bad poison ivy)
  • Supportive care:
    • Emollients, cool compresses
    • Antihistamines can help itch, but note: they don’t treat the mechanism (since histamine isn’t the driver)

Granulomatous diseases

  • Treat underlying cause (e.g., anti-TB therapy for TB)
  • Some inflammatory granulomatous conditions (e.g., sarcoidosis) may use steroids depending on clinical context (more Step 2).

Transplant rejection (high-level)

  • Immunosuppression targeting T cells (regimens vary; concept is T-cell control).

High-Yield Associations & “Buzzword → Mechanism” Map

If you see this… think Type IV:

  • “48–72 hours later”
  • Induration
  • Poison ivy, nickel, latex
  • Granulomas
  • Th1 → IFN-γ → macrophages
  • No antibodies detected
  • T-cell infiltrate

Cytokines and cells (rapid recall)

  • Th1IFN-γmacrophage activation
  • Th17IL-17neutrophil recruitment
  • CD8+ T cells → apoptosis via perforin/granzyme or Fas–FasL

Quick comparison to avoid traps

  • Serum sickness (Type III) can also occur days later—difference is immune complexes + low complement + systemic signs.
  • Urticaria/anaphylaxis (Type I) is fast and IgE/mast cell driven.

First Aid Cross-References (Where This Lives in Your Book)

Use this as a checklist while you annotate:

  • Immunology
    • Hypersensitivity reactions (Types I–IV)
    • T-cell subsets (Th1/Th17; CD8+)
    • Transplant rejection basics
  • Microbiology
    • TB: PPD, granulomas
    • Dimorphic fungi (granulomatous infections)
  • Pathology
    • Chronic inflammation and granuloma formation
  • Dermatology
    • Contact dermatitis pattern recognition

(Edition/page numbers vary, but these headings are consistent across versions.)


Rapid-Fire USMLE-Style Mini Prompts

  • A patient develops an itchy vesicular rash 2 days after hiking and brushing against plants → Type IV contact dermatitis.
  • PPD placed; at 48 hours there is 10 mm indurationTh1-mediated delayed hypersensitivity.
  • Biopsy shows caseating granulomas → chronic Th1/IFN-γ macrophage activation response (commonly TB).
  • Rejection with lymphocytic infiltrates and vascular damage weeks-months after transplant → T-cell mediated (Type IV framework).

Key Takeaways (What to Memorize)

  • Type IV = delayed, T-cell mediated (no antibodies).
  • Timing: 48–72 hours is classic.
  • Th1 → IFN-γ → macrophages (DTH, granulomas, PPD).
  • Contact dermatitis and PPD are the must-know examples.
  • Granulomas = chronic Type IV pattern against persistent antigens.